Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Vermont for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Vermont only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Vermont (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Weissgold (NPI 1437169661)

Field	Value
Entity Type	Individual
Organization	David Weissgold
Address	99 Swift St Ste 200
City	South Burlington
State	VT
ZIP	05403
Taxonomy	Ophthalmology Physician
NPI Enumerated	August 9, 2006

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

DAVID WEISSGOLD is an Ophthalmology Physician in SOUTH BURLINGTON, VT with Total Medicare revenue of $1.7M and no Medicaid billing on file; his NPI was enumerated on 2006-08-09 (~20 years ago), indicating long-standing enrollment. The absence of any Medicaid claims on record makes his practice effectively single-payer (Medicare) in the available public claims data, which will shape payer-mix and access analysis.

Revenue is highly concentrated in a small set of intravitreal injection codes: the precomputed top 3 Medicare codes (J0178, J2777, 67028) account for 79.1% of the provider's total Medicare revenue. Specifically, J0178 accounts for $1.1M (64.6% of total Medicare revenue), J2777 for $130.5K (7.6%), and 67028 for $117.5K (6.9%), showing extreme dependence on anti-VEGF drug and injection procedure billing.

The code mix and code-level dollars point to a retina/medical retina service-line focus rather than surgical retina or glaucoma specialty care: J0178 (aflibercept) drives the bulk of revenue and 67028 documents frequent isolated intravitreal injections. High utilization of diagnostic retinal imaging codes such as 92134 and fluorescein angiography (92235) alongside these injections suggests a workflow centered on chronic retinal disease management, including wet AMD and diabetic macular edema.

Competitive standing for the top revenue codes is mixed but generally indicates a modest national presence rather than dominance. J0178 ranks #749 of 3204 providers (77th percentile) and 67028 ranks #844 of 4255 providers (80th percentile), both described as "typical, unremarkable volume"—so the provider is a solid but not leading national participant for aflibercept and injection procedure volume; by contrast J2777 ranks #1601 of 2039 providers (21st percentile), placing faricimab volume below many peers.

Several diagnostic and E/M codes show notably high relative volume, implying substantial throughput for imaging and routine visits: 92134 ranks #1403 of 26868 providers (95th percentile) and 92012 ranks #916 of 17177 providers (95th percentile), both flagged as "notably above typical national volume." This elevated OCT and intermediate exam activity supports the interpretation of a high-volume retinal imaging pipeline that feeds recurring intravitreal treatment visits.

Agent mix shows preferential use of aflibercept but continued billing for other agents: J9035 (bevacizumab) produced $25.4K and ranks #295 of 1852 providers (84th percentile), while J2778 (ranibizumab) contributed $81K and ranks #796 of 1208 providers (34th percentile). These patterns suggest clinical flexibility in anti-VEGF agent selection but a clear economic reliance on aflibercept (J0178 at $1.1M).

Surgical and laser procedural codes are under-represented relative to injection and imaging services: 67228 (panretinal/retinal laser) generated $4.5K and ranks #509 of 648 providers (16th percentile) and 67145 generated $2.3K and ranks #693 of 861 providers (12th percentile). The low percentiles and small dollar totals for these codes indicate limited involvement in laser-based or higher-volume surgical retinal interventions.

Operational risk and business implications follow from the concentrated revenue base: with $1.1M of the $1.7M Medicare total tied to J0178 and the top three codes representing 79.1% of Medicare revenue, the practice has a predictable, injection-driven revenue stream but is exposed to changes in reimbursement, utilization patterns, or drug availability. Combined with the lack of Medicaid billing on file, the provider’s public-payer exposure is focused on Medicare beneficiaries, which could influence contracting strategy and patient access if payer mix or policy shifts occur.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,600	$690	$1.1M
J2777	Injection, faricimab‑svoa, 0.1 mg	4,500	$30	$130.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,450	$80	$117.5K
J2778	Injection, ranibizumab, 0.1 mg	450	$180	$81K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	600	$90	$55.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,610	$30	$46.8K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	730	$60	$42.3K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	380	$100	$38.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	320	$90	$27.5K
J9035	Injection, bevacizumab, 10 mg	460	$60	$25.4K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Vermont Distribution

David Weissgold — 7 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Vermont

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	10	740	$690	$730.2K
67028	3	10	1,220	$80	$90.1K
J2777	1	10	3,090	$30	$89.8K
J2778	1	10	450	$180	$80.9K
92014	10	100	200	$80	$19.6K
J9035	2	10	250	$50	$17.5K
92235	1	10	30	$90	$13.1K
99214	118	960	90	$70	$10.6K
99215	330	410	40	$110	$7.2K
92004	5	90	50	$90	$5.9K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Weissgold, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Michelle Young	VT	Ophthalmology Physician	$2.1M	$0
John Hinkle	VT	Ophthalmology Physician	$807.4K	$940
Retina Center Of Vermont, Inc	VT	Ophthalmology Physician	$0	$533.4K

Nearby Providers

Other providers in the same ZIP code as David Weissgold, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nfi Vermont, Inc	VT	Clinic/Center	$0	$33.6M
Bla Partners, LLC	VT	Clinical Medical Laboratory	$0	$15.2M
Timberlane Dental Group	VT	Orthodontics and Dentofacial Orthopedics Dentistry	$0	$7.5M
Tms Vt, LLC	VT	Durable Medical Equipment & Medical Supplies	$0	$2.9M
Howard Center Inc	VT	Psychiatry Physician	$0	$2M
Vermont Eye Surgery & Laser Center	VT	Ambulatory Surgical Clinic/Center	$1.8M	$2.7K
Surgi-care Inc	VT	Prosthetic/Orthotic Supplier	$0	$1.7M
City Of So Burlington	VT	Ambulance	$400.9K	$1M
Green Mountain Pediatric Dentistry, PLLC	VT	Pediatric Dentistry	$0	$1.3M
Lindsay Jernigan	VT	Clinical Psychologist	$0	$1.2M

David Weissgold — Billing Profile & Reimbursement Data

Sign up for David Weissgold — Billing Profile & Reimbursement Data policy alerts

David Weissgold — Billing Profile & Reimbursement Data

Sign up for David Weissgold — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References